Inflammatory bowel disease in children and adolescents

Pediatric Annals

Volumn 26, Issue 4, 1997, Pages 227-234

  Winesett, Michele ^a,b  

^a JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; HLA DQ ANTIGEN; HLA DR1 ANTIGEN; HLA DR2 ANTIGEN; MERCAPTOPURINE; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE; PREDNISONE; SALAZOSULFAPYRIDINE;

ACNE; ACUTE PANCREATITIS; ADRENAL INSUFFICIENCY; CATARACT; CLINICAL FEATURE; COLON RESECTION; COLONOSCOPY; CORTICOSTEROID THERAPY; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; FACE EDEMA; GENETIC PREDISPOSITION; GLAUCOMA; GROWTH RETARDATION; HEADACHE; HIRSUTISM; HUMAN; NAUSEA; NUTRITIONAL SUPPORT; REVIEW; ULCERATIVE COLITIS;

EID: 0031414379     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-19970401-05     Document Type: Review

References (20)

1. Mendeloff, AI. The epidemiology of inflammatory bowel disease. Clin Gastroenterol. 1980;9:258-270.
2. Chong SK, Blackshaw AJ, Morson BC, Williams CB, Walker-Smith JA. Prospective study of colitis in infancy and early childhood. J Pediatr Gastroenterol Nutr. 1986;5:352-358.
3. Yang H, Rotter JI. Genetics of inflammatory bowel disease. In: Targan SR, Shanahan F, eds. Inflammatory Bowel Disease: From Bench to Bedside. Baltimore, Md: Williams and Wilkins; 1994:32-64.
4. Hugot JP, Laurent-Puig P, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 1996;379:821-823.
5. Rotter JI, et al. Genetic heterogeneity between ulcerative colitis and Crohn's disease identified by molecular HLA class II association. Gastroenterology. 1992;102:A688.
6. Toyoda H, Wang SJ, Yang HY, et al. Distinct association of HLA class II genes with inflammatory bowel disease. Gastroenterology. 1993;104:741-748.
7. Sadlack B, Merz H, Schorle H, Schimiol A, Feller AC, Horack I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993;75:253-261.
8. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263-274.
9. Mombaerts P, Mizuguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 1993;75:274-282.
10. Leichtner AM, Jackson WD, Grand RJ. Ulcerative colitis. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, eds. Pediatric Gastrointestinal Disease. St Louis, Mo: Mosby; 1996:712-726.
11. Leichtner AM, Jackson WD, Grand RJ. Crohn's disease. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, eds. Pediatric Gastrointestinal Disease. St Louis, Mo: Mosby; 1996:692-711.
12. Hyams JF. Extraintestinal manifestations of inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr. 1994;19:7-21.
13. Markowitz J, Daum F. Growth impairment in pediatric inflammatory bowel disease. Am J Gastroenterol. 1994;89:319-326.
14. Motil KJ, Grand RJ, Davis-Kraft L, Ferlic LL, Smith EO. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology. 1993;105:681-691.
15. Hyams JS. Crohn's disease in children. Pediatr Clin North Am. 1996;235-254.
16. Kirschner BS. Ulcerative colitis in children. Pediatr Clin North Am. 1996;235-254.
17. Leichtner AM. Aminosalicylates for the treatment of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1995;21:245-252.
18. Sandborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflam Bowel Dis. 1995;1:48-63.
19. Telander RL. Surgical management of inflammatory bowel disease in children. In: Telander R, ed. Problems in General Surgery: Surgical Treatment of Inflammatory Bowel Disease. Philadelphia, Pa: JB Lippincott Co; 1993.
20. Gillen CD, Walmsley RS, Prior P, et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994;35:1507-1508.